# Anti-Inflammatory Lipid Mediators in Asthma

> **NCT03680976** · PHASE2 · WITHDRAWN · sponsor: **Sally E. Wenzel MD**

## Conditions studied

- Asthma

## Interventions

- **DRUG:** CXA-10
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT03680976
- **Lead sponsor:** Sally E. Wenzel MD
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** WITHDRAWN
- **Start date:** —
- **Primary completion:** 2021-04
- **Final completion:** 2021-04
- **Target enrollment:** 0 (ACTUAL)
- **Why stopped:** The study will not take place at the University of Pittsburgh
- **Last updated:** 2018-09-21


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03680976

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03680976, "Anti-Inflammatory Lipid Mediators in Asthma". Retrieved via AI Analytics 2026-05-25 from https://api.ai-analytics.org/clinical/NCT03680976. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*